In another study, Hansen et al. found that the expression of topoisomerase II was lower in Hsp27 transfected MDA-MB-231 breast cancer cells than in controls and inhibited the doxorubicin-induced apoptosis, suggesting a potential mechanism explaining the Hsp27-mediated cancer resistance. This evidence concerns the gene HSPB1 and cancer.